S. Cohen

431 total citations
8 papers, 250 citations indexed

About

S. Cohen is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, S. Cohen has authored 8 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 2 papers in Hematology. Recurrent topics in S. Cohen's work include Rheumatoid Arthritis Research and Therapies (5 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). S. Cohen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). S. Cohen collaborates with scholars based in United States, South Africa and Austria. S. Cohen's co-authors include Larry W. Moreland, Michael E. Weinblatt, Scott W. Baumgartner, Elizabeth A. Tindall, Ken J. Bulpitt, A. Weaver, Richard W. Martin, Daniel Burge, Michael Schiff and R. Fleischmann and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Medical Genetics and The American Journal of the Medical Sciences.

In The Last Decade

S. Cohen

8 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Cohen United States	5	148	87	50	50	33	8	250
V. Bykerk United States	9	161 1.1×	58 0.7×	33 0.7×	28 0.6×	38 1.2×	19	249
Cathrin Nikolaisen Norway	9	241 1.6×	50 0.6×	37 0.7×	133 2.7×	11 0.3×	9	332
Mahmood M. T. M. Ally South Africa	9	214 1.4×	48 0.6×	17 0.3×	55 1.1×	17 0.5×	23	316
Víctor R. Pimentel-Quiroz Peru	9	194 1.3×	29 0.3×	45 0.9×	81 1.6×	32 1.0×	38	236
Marta Novella-Navarro Spain	9	172 1.2×	41 0.5×	38 0.8×	49 1.0×	8 0.2×	41	243
S Wassenberg Germany	6	290 2.0×	126 1.4×	39 0.8×	105 2.1×	10 0.3×	8	408
Emily Sutton United Kingdom	7	194 1.3×	37 0.4×	89 1.8×	95 1.9×	49 1.5×	15	298
Hee Jung Ryu South Korea	11	191 1.3×	41 0.5×	19 0.4×	92 1.8×	29 0.9×	22	320
Yukiko Takakuwa Japan	9	104 0.7×	25 0.3×	20 0.4×	68 1.4×	56 1.7×	35	219
Peigen He China	6	86 0.6×	30 0.3×	17 0.3×	48 1.0×	12 0.4×	8	147

Countries citing papers authored by S. Cohen

Since Specialization

Citations

This map shows the geographic impact of S. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cohen more than expected).

Fields of papers citing papers by S. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cohen. The network helps show where S. Cohen may publish in the future.

Co-authorship network of co-authors of S. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of S. Cohen. A scholar is included among the top collaborators of S. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Cohen. S. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Fleischmann, Roy, J. Wollenhaupt, S. Cohen, et al.. (2018). SAT0247 Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial. Annals of the Rheumatic Diseases. 77. 985–986. 4 indexed citations

2.

Heijde, D. van der, Yoshiya Tanaka, R Fleischmann, et al.. (2012). Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study. Arthritis & Rheumatism. 64(10). 4 indexed citations

3.

Moreland, Larry W., S. Cohen, Scott W. Baumgartner, et al.. (2001). Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.. PubMed. 28(6). 1238–44. 154 indexed citations

4.

Schiff, M., et al.. (2001). FRI0077 Durability and rapidity of response for rheumatoid arthritis patients receiving therapy with anakinra (il-1ra). Annals of the Rheumatic Diseases. 60. A477–A477. 5 indexed citations

5.

Moreland, Larry W., et al.. (2001). FRI0080 Long-term use of enbrel® (etanercept) in patients with dmard-refractory rheumatoid arthritis. Annals of the Rheumatic Diseases. 60. A478–A478. 3 indexed citations

6.

Cohen, S.. (1999). Idiopathic Pulmonary Hemosiderosis. The American Journal of the Medical Sciences. 317(1). 67–74. 30 indexed citations

7.

Budiman‐Mak, Elly, et al.. (1994). Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).. PubMed. 89(7). 1014–20. 14 indexed citations

8.

Cohen, S.. (1982). Familial polyposis coli and its extracolonic manifestations.. Journal of Medical Genetics. 19(3). 193–203. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact